Association Between Colchicine and Risk of Diabetes Among the Veterans Affairs Population With Gout
Authors:
- 1 June 2015
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 37 (6) , 1206-1215
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008Arthritis & Rheumatism, 2011
- Gout treatment and comorbidities: a retrospective cohort study in a large US managed care populationBMC Musculoskeletal Disorders, 2011
- The role of hyperuricemia in vascular disordersCurrent Opinion in Rheumatology, 2009
- Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profileRheumatology, 2008
- EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2006
- The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meetingProstate Cancer and Prostatic Diseases, 2006
- GoutNew England Journal of Medicine, 2003
- Update on colchicine and its mechanism of actionCurrent Rheumatology Reports, 2002
- Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute goutArthritis & Rheumatism, 1988
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987